Arquist 125 mikrograma po potisku, stlačeni inhalat, suspenzija
| Name | Arquist 125 mikrograma po potisku, stlačeni inhalat, suspenzija |
|---|---|
| Former Name | Truflo 125 mikrograma/dozi, stlačeni inhalat, suspenzija |
| Marketing Authorisation Number | HR-H-396395512 |
| Active Substance | flutikazonpropionat |
| Composition | jedna odmjerena doza sadrži 125 mikrograma flutikazonpropionata |
| Pharmaceutical Form | stlačeni inhalat, suspenzija |
| Manufacturer | S&D Pharma CZ, spol. s r.o, Pchery (Pharmos a.s. facility), Češka Glenmark Pharmaceuticals s.r.o., Vysoké Mýto, Češka Cipla Europe NV, Antwerpen, Belgija |
| Marketing Authorisation Holder | Cipla Europe NV, De Keyserlei 60C, Bus 1301, Antwerpen, Belgija |
| Marketing Authorisation Date | 13.08.2020 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/19-02/148 |
| Registration Number | 381-12-01/70-20-03 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | R03BA05 |
| Marketing status | trajni prekid opskrbe |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
